Swedish biotech expansion: ReNerve signed an exclusive distribution deal with STC to commercialise its NervAlign products across Hong Kong, Macau and the Greater Bay Area, with first stocking orders already shipping and a target addressable population of ~88 million. Health & biotech: New trial results suggest many breast cancer patients can safely skip chemotherapy using a gene test (Prosigna), and separate research reports antibiotic use can leave gut microbiome changes detectable up to 8 years later. AI at work: A Brookings study finds Europe is slower than the US to integrate AI into daily operations, though Sweden adoption rates are relatively high. Industrial tech: ABB quantified a large motor efficiency “gap” using data from its Västerås output, arguing small efficiency gains can translate into major lifetime electricity savings. Nuclear infrastructure: Finland’s Onkalo spent-fuel repository is nearing approval for operations, with licensing expected after a June safety assessment. Security & infrastructure: Reporting highlights growing threats to undersea cables and the need for coordinated protection of critical undersea infrastructure. AI/industry partnerships: SKF is teaming with Tata Consultancy Services to modernise its IT and build an AI foundation for manufacturing operations. Privacy & surveillance: Serbia’s facial recognition build-out raises legality concerns, including live ingestion from multiple camera sources.